Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise-The Energy Report (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Brazil Lithium Developer Contracts 71% of Neves Budget 16% Below DFS

% of readers think this story is Fact. Add your two cents.


Source: Streetwise Reports 09/15/2026

Atlas Lithium has contracted 71% of direct capital spending for its Neves Project at 16% under budget estimates. Learn what this means for the fully permitted Brazilian lithium asset and retail investors.

Atlas Lithium Corp. (ATLX:NASDAQ) has taken a major step forward by locking in contracts covering 71% of the direct capital expenditures for its 100%-owned Neves Project in Brazil. The agreements came in approximately 16% below the levels outlined in the project’s Definitive Feasibility Study.

This development reduces execution risk at a time when lithium demand continues to grow rapidly. Global consumption rose 45% year over year through May 2026, according to data cited by the company from Albemarle Corporation, while new supply additions have faced delays from limited spodumene availability and slower ramps at certain mines.

Why the Contracted Budget Matters for Investors

Contracting more than two-thirds of direct capital spending below budget demonstrates disciplined project management. The scope includes earthworks, civil construction, electromechanical assembly of the Dense Media Separation plant, crushing systems, electrical infrastructure, detailed engineering, construction management, and in-country logistics. Each award followed competitive bidding and was finalized at or below DFS estimates.

The company’s corporate presentation listed total direct capital expenditures of US$57.56 million. Key line items included US$12.15 million for DMS plant installation, US$9.45 million for earthworks, US$6.90 million for mining, US$6.89 million for the crushing area, and US$6.25 million for civil works.

Company Position and Key Assets

Atlas Lithium holds a fully permitted project with its DMS lithium processing plant already delivered to Brazil and ready for assembly. The Neves Project features a two-stage DMS circuit targeting a final spodumene concentrate grade of 5.5% Li2O and annual production capacity near 150,000 tons.

DFS metrics include average annual SC5.5 production of 146,000 tons, plant throughput of 1.1 million tons per year, and an initial mine life of 6.5 years. Life-of-mine ore processed totals 7.253 million tons at an average Li2O grade of 1.17%.

The project also benefits from regional exploration at the 100%-owned Salinas Project, where early drill results showed positive indications of near-surface mineralization.

Lithium Market Timing

According to a September 9 report from IndexBox, broader demand fundamentals support lithium-based products, with Asia-Pacific accounting for 55% to 65% of global lithium frits demand.

Shanghai Metals Market reported on September 10 that spot lithium carbonate prices had “drifted lower” during the September 7 to September 10 period, while downstream buyers actively purchased on dips. Trading Economics reported on September 10 that lithium carbonate was at CNY 144,750 per metric ton, down 0.69% for the day yet up 98.70% year over year.

Analyst View and Valuation Context

H.C. Wainwright & Co. analyst Heiko F. Ihle reiterated a “Buy” rating on Atlas Lithium following the September 9 update. The firm lowered its price target to US$11.50 from US$12.50, citing a shift in modeled first production to the first quarter of 2028 and slight dilution in its updated model.

Ihle noted the contracting progress as a clear sign of management execution. [OWNERSHIP_CHART-11040]

Share Structure and Near-Term Considerations1

Atlas Lithium Corp. has a market cap of approximately US$95 million, with about 30.10 million shares outstanding. The 52-week range is approximately US$2.55-US$8.25.

Institutions own 10% of shares, insiders and management own 23%, strategic investors own 7%, and retail investors hold the remaining 60%.

Key Investor Takeaways

  • 71% of direct capital expenditures are now under contract at 16% below DFS budget levels, lowering project risk.
  • The Neves Project is fully permitted, with the processing plant already in Brazil and ready for assembly.
  • DFS outlines average annual production of 146,000 tons of SC5.5 spodumene concentrate over an initial 6.5-year mine life.
  • Lithium market data shows strong demand growth and low inventories, supporting long-term fundamentals.
  • H.C. Wainwright maintains a Buy rating with a US$11.50 price target after the latest update.
  • Market cap near US$95 million leaves room for re-rating if execution milestones are met on schedule.

Common Questions from Investors

How much of the Neves Project budget is now contracted?

Approximately 71% of direct capital expenditures are supported by executed contracts that came in 16% below the DFS budget.

What is the current status of the processing plant?

The fully paid DMS lithium processing plant has been delivered to Brazil and is ready for assembly at the permitted site.

What production does the DFS project for Neves?

The study outlines average annual SC5.5 production of 146,000 tons with a 6.5-year initial mine life.

What rating does the covering analyst maintain?

H.C. Wainwright reiterated a Buy rating with a US$11.50 price target after the September 9 contract update.

Atlas Lithium’s progress on contracting and permitting positions the company to advance the Neves Project amid favorable lithium demand trends. Retail investors should monitor upcoming construction milestones and any updates on production timing.

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. Atlas Lithium is a billboard sponsor of Streetwise Reports. The company pays a monthly sponsorship fee of US$3,000–US$6,000 for banner advertising and an enhanced company profile page. Streetwise Reports’ editorial content is fully independent and is not influenced by sponsorship.
  2. As of the date of this article, officers, contractors, shareholders, and/or employees of Streetwise Reports LLC (including members of their household) own securities of Atlas Lithium.
  3. Jordan Nova wrote this article for Streetwise Reports LLC and provides services to Streetwise Reports as an employee.
  4. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

1. Ownership and Share Structure Information

The information listed above was updated on the date this article was published and was compiled from information from the company and various other data providers.

( Companies Mentioned: ATLX:NASDAQ, )


Source: https://www.streetwisereports.com/article/2026/09/14/brazil-lithium-developer-contracts-71-of-neves-budget-16-below-dfs.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login